{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T22:25:54Z","timestamp":1757543154364},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,8,13]],"date-time":"2010-08-13T00:00:00Z","timestamp":1281657600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s10753-010-9236-x","type":"journal-article","created":{"date-parts":[[2010,8,12]],"date-time":"2010-08-12T08:07:30Z","timestamp":1281600450000},"page":"314-318","source":"Crossref","is-referenced-by-count":5,"title":["Inhibitory Effect of Farnesylthiosalicylic Acid on Mediators Release by Mast Cells: Preferential Inhibition of Prostaglandin D2 and Tumor Necrosis Factor-\u03b1 Release"],"prefix":"10.1007","volume":"34","author":[{"given":"Adam","family":"Mor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ofer","family":"Ben-Moshe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoseph A.","family":"Mekori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoel","family":"Kloog","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,8,13]]},"reference":[{"key":"9236_CR1","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.drup.2005.11.002","volume":"8","author":"R Blum","year":"2005","unstructured":"Blum, R., and Y. Kloog. 2005. Tailoring Ras pathway\u2014inhibitor combinations for cancer therapy. Drug Resistance Update 8: 369\u2013380.","journal-title":"Drug Resistance Update"},{"key":"9236_CR2","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.carpath.2008.10.009","volume":"19","author":"R Pando","year":"2010","unstructured":"Pando, R., I. Barshack, A. Raz, G. Luboshits, R. Haklai, S. Maysel-Auslender, Y. Kloog, G. Keren, and J. George. 2010. The Ras antagonist farnesylthiosalicylic acid ameliorates experimental myocarditis in the rat. Cardiovascular Pathology 19: 94\u2013101.","journal-title":"Cardiovascular Pathology"},{"key":"9236_CR3","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.jaci.2009.08.035","volume":"124","author":"DD Matcalfe","year":"2009","unstructured":"Matcalfe, D.D., R.D. Peavy, and A.M. Gilfillan. 2009. Mechanisms of mast cell signaling in anaphylaxis. The Journal of Allergy and Clinical Immunology 124: 639\u2013646.","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"9236_CR4","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jaci.2008.07.024","volume":"122","author":"I Shefler","year":"2008","unstructured":"Shefler, I., Y.A. Mekori, and A. Mor. 2008. Stimulation of human mast cells by activated T cells leads to N-Ras activation through Ras guanine nucleotide releasing protein 1. J Allergy Clin Immunol 122: 1222\u20135.","journal-title":"J Allergy Clin Immunol"},{"key":"9236_CR5","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1046\/j.1365-2249.1997.4541471.x","volume":"110","author":"D Baram","year":"1997","unstructured":"Baram, D., M. Rashkovsky, R. Hershkoviz, I. Drucker, T. Reshef, S. Ben-Shitrit, and Y.A. Mekori. 1997. Inhibitory effects of low molecular weight heparin on mediator release by mast cells: preferential inhibition of cytokine production and mast cell-dependent cutaneous inflammation. Clinical and Experimental Immunology 110: 485\u2013491.","journal-title":"Clinical and Experimental Immunology"},{"key":"9236_CR6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jaci.2009.11.031","volume":"125","author":"SH Sicherer","year":"2010","unstructured":"Sicherer, S.H., and D.Y.M. Leung. 2010. Advances in allergic skin disease, anaphylaxis, and hypersensitivity reactions to foods, drugs, and insects in 2009. The Journal of Allergy and Clinical Immunology 125: 85\u201397.","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"9236_CR7","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10753-009-9165-8","volume":"33","author":"A Mor","year":"2010","unstructured":"Mor, A., I. Shefler, P. Salamon, Y. Kloog, and Y.A. Mekori. 2010. Characterization of ERK activation in human mast cells stimulated by contact with T cells. Inflammation 33: 119\u2013125.","journal-title":"Inflammation"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-010-9236-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10753-010-9236-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-010-9236-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T23:38:03Z","timestamp":1559259483000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10753-010-9236-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,13]]},"references-count":7,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["9236"],"URL":"https:\/\/doi.org\/10.1007\/s10753-010-9236-x","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,13]]}}}